Dogwood Therapeutics (DWTX) Deferred Taxes (2024 - 2026)

Dogwood Therapeutics has reported Deferred Taxes for 3 years, with the latest figure at -$2.5 million in Q2 2026.

• On a quarterly basis, Deferred Taxes fell 1677952.35% year-over-year to -$2.5 million in Q2 2026; TTM through Jun 2026 was -$2.5 million, a 1397.87% decrease from a year earlier, with the FY2025 full-year figure at $221096.0, up 44055.47% from the prior year.
• Deferred Taxes was -$2.5 million for Q2 2026 at Dogwood Therapeutics, down from $1193.0 in the prior quarter.
• The five-year high for Deferred Taxes was $190542.0 in Q1 2025, with the low at -$2.5 million in Q2 2026.
• Average Deferred Taxes over 3 years is -$325459.1, with a median of $149.0 recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Deferred Taxes jumped 6430.22% in 2025, then sank 1677952.35% in 2026.
• Over 3 years, Deferred Taxes stood at -$503.0 in 2024, then surged by 6430.22% to $31841.0 in 2025, then sank by 7951.51% to -$2.5 million in 2026.
• The last three Deferred Taxes figures came in at -$2.5 million (Q2 2026), $1193.0 (Q1 2026), and $31841.0 (Q4 2025), per Business Quant data.